272 related articles for article (PubMed ID: 8712771)
1. Antimicrobial-resistant pathogens in the 1990s.
Jacoby GA
Annu Rev Med; 1996; 47():169-79. PubMed ID: 8712771
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Cockerill FR; Steckelberg JM
Diagn Microbiol Infect Dis; 1998 Feb; 30(2):89-92. PubMed ID: 9554174
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.
Sahm DF; Marsilio MK; Piazza G
Clin Infect Dis; 1999 Aug; 29(2):259-63. PubMed ID: 10476722
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
Sweeney MT; Zurenko GE
Antimicrob Agents Chemother; 2003 Jun; 47(6):1902-6. PubMed ID: 12760865
[TBL] [Abstract][Full Text] [Related]
5. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
6. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
[No Abstract] [Full Text] [Related]
7. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium.
Hegstad K; Mikalsen T; Coque TM; Werner G; Sundsfjord A
Clin Microbiol Infect; 2010 Jun; 16(6):541-54. PubMed ID: 20569265
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
Severina E; Severin A; Tomasz A
J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium.
Du X; Hua X; Qu T; Jiang Y; Zhou Z; Yu Y
J Chemother; 2014 Aug; 26(4):217-21. PubMed ID: 24070269
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance: an ecological approach to a growing threat.
Gordon SM
Cleve Clin J Med; 1998 May; 65(5):232-6. PubMed ID: 9599905
[No Abstract] [Full Text] [Related]
11. Emerging antibiotic resistance.
Bonafede M; Rice LB
J Lab Clin Med; 1997 Dec; 130(6):558-66. PubMed ID: 9422329
[No Abstract] [Full Text] [Related]
12. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
Livermore DM; Warner M; Mushtaq S; North S; Woodford N
Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
[TBL] [Abstract][Full Text] [Related]
14. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.
de Kraker ME; Jarlier V; Monen JC; Heuer OE; van de Sande N; Grundmann H
Clin Microbiol Infect; 2013 Sep; 19(9):860-8. PubMed ID: 23039210
[TBL] [Abstract][Full Text] [Related]
15. A call to arms: the imperative for antimicrobial stewardship.
Bartlett JG
Clin Infect Dis; 2011 Aug; 53 Suppl 1():S4-7. PubMed ID: 21795727
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin resistance gene transfer from Enterococcus faecalis and E. faecium to Staphylococcus aureus, S. intermedius and S. hyicus.
Noble WC; Rahman M; Karadec T; Schwarz S
Vet Microbiol; 1996 Sep; 52(1-2):143-52. PubMed ID: 8914258
[TBL] [Abstract][Full Text] [Related]
19. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
[TBL] [Abstract][Full Text] [Related]
20. The challenge of antibiotic resistance.
Levy SB
Sci Am; 1998 Mar; 278(3):46-53. PubMed ID: 9487702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
